{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:40:28Z","timestamp":1762101628398},"reference-count":58,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.semnephrol.2014.08.003","type":"journal-article","created":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T06:07:47Z","timestamp":1416463667000},"page":"498-505","source":"Crossref","is-referenced-by-count":14,"title":["Ambulatory Blood Pressure and Adherence Monitoring: Diagnosing Pseudoresistant Hypertension"],"prefix":"10.1016","volume":"34","author":[{"given":"Michel","family":"Burnier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregoire","family":"Wuerzner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.08.003_bib1","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1097\/HJH.0b013e3282f0580f","article-title":"ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib2","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib3","doi-asserted-by":"crossref","first-page":"e003423","DOI":"10.1136\/bmjopen-2013-003423","article-title":"Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study","volume":"3","author":"Joffres","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-7176.2011.00556.x","article-title":"Refractory hypertension: definition, prevalence, and patient characteristics","volume":"14","author":"Acelajado","year":"2012","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1524-6175.2002.02045.x","article-title":"Success and predictors of BP control in diverse North American settings: the Antihypertensive and Lipid-Lowering and Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"4","author":"Cushman","year":"2002","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib6","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib7","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/HYPERTENSIONAHA.111.170308","article-title":"Prevalence of resistant hypertension in the United States, 2003\u20132008","volume":"57","author":"Persell","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib8","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/CIRCULATIONAHA.111.030189","article-title":"Uncontrolled and apparent treatment resistant hypertension in the U.S. 1988\u20132008","volume":"124","author":"Egan","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/HYPERTENSIONAHA.110.168948","article-title":"Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring","volume":"57","author":"de la Sierra","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/HYPERTENSIONAHA.113.02026","article-title":"Refractory hypertension: determination of prevalence, risk factors, and comorbidities in a large, population-based cohort","volume":"63","author":"Calhoun","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib11","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib12","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1097\/HJH.0b013e32834a8a42","article-title":"Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): a risk score to identify those at high-risk","volume":"29","author":"Gupta","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/HYPERTENSIONAHA.113.02148","article-title":"Ambulatory blood pressure measurement: what is the international consensus?","volume":"62","author":"O\u05f3Brien","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(87)91086-5","article-title":"Are some hypertensive patients overtreated? A prospective study of ambulatory blood pressure recording","volume":"2","author":"Waeber","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib15","doi-asserted-by":"crossref","first-page":"d4891","DOI":"10.1136\/bmj.d4891","article-title":"Management of hypertension: summary of NICE guidance","volume":"343","author":"Krause","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib16","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1001\/jama.291.11.1342","article-title":"Cardiovascular prognosis of \"masked hypertension\" detected by blood pressure self-measurement in elderly treated hypertensive patients","volume":"291","author":"Bobrie","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.108.115154","article-title":"Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease","volume":"53","author":"Pogue","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jash.2013.02.002","article-title":"Recognition and management of masked hypertension: a review and novel approach","volume":"7","author":"Yano","year":"2013","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1161\/HYPERTENSIONAHA.111.00289","article-title":"International Database on Ambulatory blood pressure in Relation to Cardiovascular Outcomes Investigators. Masked hypertension in diabetes mellitus: treatment implications for clinical practice","volume":"61","author":"Franklin","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib20","first-page":"931","article-title":"Masked hypertension in diabetes mellitus","volume":"61","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3109\/07420528.2012.701135","article-title":"Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring","volume":"30","author":"R\u00edos","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib22","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.jacc.2012.12.061","article-title":"Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients","volume":"61","author":"De Nicola","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib23","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1161\/HYPERTENSIONAHA.113.00687","article-title":"Measuring, analyzing and managing drug adherence in resistant hypertension","volume":"62","author":"Burnier","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib24","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","article-title":"Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients","volume":"125","author":"Naderi","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib25","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/bmj.39553.670231.25","article-title":"Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories","volume":"336","author":"Vrijens","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2165\/11537400-000000000-00000","article-title":"Concordance of adherence measurement using self-reported adherence questionnaires and medication monitoring devices","volume":"28","author":"Shi","year":"2010","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1474-5151(03)00058-6","article-title":"Measuring adherence in a hypertension clinical trial","volume":"2","author":"Hamilton","year":"2003","journal-title":"Eur J Cardiovasc Nurs"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib28","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00004872-200102000-00022","article-title":"Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions","volume":"19","author":"Burnier","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib29","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/HYPERTENSIONAHA.112.192096","article-title":"The association between medication adherence and treatment intensification with BP control in resistant hypertension","volume":"60","author":"Daugherty","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib30","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med Care"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","article-title":"Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial","volume":"54","author":"Pimenta","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib33","doi-asserted-by":"crossref","first-page":"165","DOI":"10.5664\/jcsm.2420","article-title":"Effect of oral appliances on blood pressure in obstructive sleep apnea: a systematic review and meta-analysis","volume":"9","author":"Iftikhar","year":"2013","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib34","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2013.281250","article-title":"Spanish Sleep Network. Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial","volume":"310","author":"Mart\u00ednez-Garc\u00eda","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib35","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1001\/archinte.1991.00400090078014","article-title":"Resistant hypertension in a tertiary care clinic","volume":"151","author":"Yakovlevitch","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib36","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJM199208203270808","article-title":"Refractory hypertension","volume":"327","author":"Setaro","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib37","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1161\/HYPERTENSIONAHA.113.01448","article-title":"Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network","volume":"62","author":"Egan","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib38","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/HYPERTENSIONAHA.111.190637","article-title":"Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate","volume":"59","author":"Peterzan","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib39","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone compared with hydrochlorothiazide in reducing cardiovascular events: systematic review and network meta-analyses","volume":"59","author":"Roush","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib40","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/01.HYP.0000203309.07140.d3","article-title":"Comparative antihypertensive effects of hydrochlorothiazide and chlorthalidone on ambulatory and office blood pressure","volume":"47","author":"Ernst","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib41","doi-asserted-by":"crossref","first-page":"F133","DOI":"10.1152\/ajprenal.00227.2002","article-title":"Upregulation of Na+ transporter abundances in response to chronic thiazide or loop diuretic treatment in rats","volume":"284","author":"Na","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib42","doi-asserted-by":"crossref","first-page":"F923","DOI":"10.1152\/ajprenal.00015.2002","article-title":"Sodium transporter abundance profiling in kidney: effect of spironolactone","volume":"283","author":"Nielsen","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/00005344-199703000-00010","article-title":"Sequential nephron blockade breaks resistance to diuretics in edematous states","volume":"29","author":"Knauf","year":"1997","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib44","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/HJH.0b013e3283551e98","article-title":"Sequential nephron blockade versus sequential renin-angiotensin system blockade in resistant hypertension: a prospective, randomized, open blinded endpoint study","volume":"30","author":"Bobrie","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib45","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1001\/archinte.168.11.1159","article-title":"Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion","volume":"168","author":"Gaddam","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jash.2010.10.001","article-title":"The effect of low-dose spironolactone on resistant hypertension","volume":"4","author":"Engbaek","year":"2010","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib48","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1097\/HJH.0b013e32833d4c99","article-title":"Management of resistant arterial hypertension: role of spironolactone versus double blockade of the renin-angiotensin-aldosterone system","volume":"28","author":"Alvarez-Alvarez","year":"2010","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib49","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","article-title":"The role of spironolactone in the treatment of patients with refractory hypertension","volume":"15","author":"Ouzan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib50","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0895-7061(03)01032-X","article-title":"Efficacy of low-dose spironolactone in subjects with resistant hypertension","volume":"16","author":"Nishizaka","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib51","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjhyper.2005.11.016","article-title":"Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension","volume":"19","author":"Sharabi","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib52","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/HJH.0b013e328014954d","article-title":"Low-dose spironolactone in the management of resistant hypertension: a surveillance study","volume":"25","author":"Lane","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/HYPERTENSIONAHA.109.140988","article-title":"Efficacy of spironolactone therapy in patients with true resistant hypertension","volume":"55","author":"de Souza","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib54","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","article-title":"Spironolactone reduces severity of obstructive sleep apnoea in patients with resistant hypertension: a preliminary report","volume":"24","author":"Gaddam","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib55","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"V\u00e1clav\u00edk","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib56","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jash.2012.01.003","article-title":"Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial","volume":"6","author":"Bakris","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib57","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1161\/CIRCULATIONAHA.112.000949","article-title":"Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension","volume":"128","author":"Mahfoud","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.08.003_bib58","first-page":"868","article-title":"Blood pressure changes after renal denervation at 10 European expert centers","volume":"12","author":"Persu","year":"2013","journal-title":"J Hum Hypertens"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514001089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T01:28:45Z","timestamp":1598491725000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514001089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0270929514001089"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.08.003","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}